Colistin, doxycycline and Labetalol-meropenem combination are the most active against XDR-Carbapenem-resistant Acinetobacter baumannii: Role of a novel transferrable plasmid conferring carbapenem resistance
This study aimed to evaluate the antimicrobial susceptibility and combination of a beta-blocker, labetalol (LAB) and meropenem (MEM) on Carbapenem-resistant (CR) A. baumannii clinical isolates. A total of 43 CR- A. baumannii were isolated of which 37 (86.6 %) and 28 (65 %) exhibited MDR and XDR phen...
| Published in: | Diagnostic Microbiology and Infectious Disease |
|---|---|
| Main Author: | |
| Format: | Article |
| Language: | English |
| Published: |
Elsevier Inc.
2024
|
| Online Access: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85206250226&doi=10.1016%2fj.diagmicrobio.2024.116558&partnerID=40&md5=6b95db5a0108323f9dc67fc28b75b7d0 |